Plasma AR and abiraterone-resistant prostate cancer. (Q53810482)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

title

Plasma AR and abiraterone-resistant prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Suzanne Carreira

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Francesca Demichelis

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Gerhardt Attard

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Alessandro Romanel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Alessandro Romanel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Delila Gasi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Vincenza Conteduca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Samanta Salvi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Giorgia Gurioli

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

21

Ugo De Giorgi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

16

Jane Goodall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Anuradha Jayaram

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Nicola Casiraghi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Daniel Wetterskog

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Dino Amadori

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Zafeiris Zafeiriou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Diletta Bianchini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Valentina Casadio

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Anna Wingate

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Roberta Ferraldeschi

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Nina Tunariu

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Penny Flohr

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

Johann S de Bono

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

1 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

Science Translational Medicine

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

issue

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

312re10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

Abiraterone and increased survival in metastatic prostate cancer

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Integrative clinical genomics of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

The evolutionary history of lethal metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Tumor clone dynamics in lethal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Unraveling the clonal hierarchy of somatic genomic aberrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Sequence Divergence, Functional Constraint, and Selection in Protein Evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

The Ka/Ks ratio: diagnosing the form of sequence evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Abiraterone in metastatic prostate cancer without previous chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

ASEQ: fast allele-specific studies from next-generation sequencing data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCITRANSLMED.AAC9511

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6112410

10.1126/SCITRANSLMED.AAC9511

2 November 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

26537258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537258 AND SRC:MED&resulttype=core&format=json